Skip to content
  • Products & Services
    • SEQ
    • Covid19-qPCR
    • Pathogenicity Calculator
  • Our Company
    • About Us
    • Careers
    • Contact Us
    • Certifications & Compliances
  • Science Hub
    • Blog
    • White Papers
    • Citations
  • Products & Services
    • SEQ
    • Covid19-qPCR
    • Pathogenicity Calculator
  • Our Company
    • About Us
    • Careers
    • Contact Us
    • Certifications & Compliances
  • Science Hub
    • Blog
    • White Papers
    • Citations
Sign In to SEQ
Schedule A Demo

Apparent efficacy of NMDAR antagonist use as a targeted therapy for status epilepticus in an infant with ATP1A2-related developmental epileptic encephalopathy

Seizure: European Journal of Epilepsy, 2025By Ahmet Can TurkogluMarch 1, 2025Leave a comment

Leman Tekin Orgun, Adnan Deniz, Ayfer Sakarya Güneş, Gökçe Cırdı,
Bülent Kara et al.

Genomize_logo
info@genomize.com
Linkedin Facebook Twitter Instagram

Products & Services

  • SEQ Platform
  • Covid19-qPCR
  • Pathogenicity Calculator

Our Company

  • About Us
  • Careers
  • Contact Us
  • Certifications & Compliances

Science Hub

  • Blog
  • White Papers
  • Citations
© 2025 Genomize. All rights reserved.
Go to Top